Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019

Published:2021-01 Issue:1 Volume:159 Page:85-92
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Rajter Juliana Cepelowicz,Sherman Michael S.,Fatteh Naaz,Vogel Fabio,Sacks Jamie,Rajter Jean-Jacques

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference11 articles.

1. Safety of high-dose ivermectin: a systematic review and meta-analysis;Navarro;J Antimicrobial Chemother,2020

2. Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond;Boldescu;Nat Rev Drug Discov,2017

3. Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus;Wagstaff;Biochem J,2012

4. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro;Caly;Antiviral Res,2020

5. Safety and pharmacokinetic profile of fixed dose ivermectin with an innovative 18 mg tablet in healthy adult volunteers;Munoz;PLoS Negl Trop Dis,2018

Cited by 167 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug repurposing: Clinical practices and regulatory pathways;Perspectives in Clinical Research;2024-09-10

2. Unlocking insights: Navigating COVID-19 challenges and Emulating future pandemic Resilience strategies with strengthening natural immunity;Heliyon;2024-08

3. Pandemic, science and health: between determinisms and determinations;Journal of Public Health;2024-07-27

4. Timing of antibiotic treatment identifies distinct clinical presentations among patients presenting with suspected septic shock;Journal of the American College of Emergency Physicians Open;2024-04

5. Efficacy and limitations of repurposed drugs and vaccines for COVID-19;Journal of Medicine, Surgery, and Public Health;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3